Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started
Sign up to stay up to date with the stocks you care about
Follow Orgenesis Inc.

Get SEC filing alerts via email and in your feed for Orgenesis Inc.

ORGS

Orgenesis Inc.

About Orgenesis Inc.

Orgenesis Inc. is a global biotech company specializing in cell and gene therapies (CGTs) with a focus on autologous treatments. It develops, processes, and commercializes advanced therapies for immuno-oncology, metabolic, regenerative, and antiviral diseases. Utilizing its proprietary Point-of-Care (POCare) platform, the company offers decentralized, automated manufacturing near patients, licensing therapies, and collaborating with research institutes and hospitals worldwide to improve access and reduce costs.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Orgenesis Inc.

1
1
2
1